English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90069/105176 (86%)
Visitors : 6566176      Online Users : 536
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/16221


    Title: BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.
    Authors: ;Woodward, W.A.,;Yu, D.,;Hortobagyi, G.N.;洪明奇;Hung, Mien-Chie
    Contributors: 生物科技學系
    Date: 2012
    Issue Date: 2012-11-23 17:10:07 (UTC+8)
    Abstract: "Breast cancer initiating cells (BCICs), which can fully recapitulate the tumor origin and are often resistant to
    chemo- and radiotherapy, are currently considered as a major obstacle for breast cancer treatment. Here, we
    show that BIKDD, a constitutively active mutant form of proapoptotic gene, BIK, effectively induces
    apoptosis of breast cancer cells and synergizes with lapatinib. Most importantly, BikDD significantly reduces
    BCICs through co-antagonism of its binding partners Bcl-2, Bcl-xL, and Mcl-1, suggesting a potential
    therapeutic strategy targeting BCICs. Furthermore, we developed a cancer-specific targeting approach for
    breast cancer that selectively expresses BikDD in breast cancer cells including BCICs, and demonstrated
    its potent antitumor activity and synergism with lapatinib in vitro and in vivo."
    Relation: CANCER CELL
    Appears in Collections:[生物科技學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML149View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback